Frankfurt
07.01.26 | 09:59
1,530 Euro
+0,66 % +0,010
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.12.25 | Diaceutics PLC - PDMR Shareholding/SIP & Total Voting Rights | - | RNS | ||
| 28.11.25 | Diaceutics PLC - PDMR Shareholding/SIP & Total Voting Rights | - | RNS | ||
| 04.11.25 | Diaceutics PLC - PDMR Shareholding/Share Incentive Plan and TVR | - | RNS | ||
| DIACEUTICS Aktie jetzt für 0€ handeln | |||||
| 01.10.25 | Diaceutics PLC - PDMR Shareholding/Share Incentive Plan and TVR | 2 | RNS | ||
| 23.09.25 | Diaceutics auf Kurs zur Jahresprofitabilität: Aktie legt zu | 1 | Investing.com Deutsch | ||
| 23.09.25 | Diaceutics PLC - H1 2025 Results | - | RNS | ||
| 11.09.25 | Diaceutics PLC - Notice of Results | - | RNS | ||
| 02.09.25 | Diaceutics PLC - PDMR Shareholding/Share Incentive Plan and TVR | - | RNS | ||
| 05.08.25 | Diaceutics PLC - Diaceutics at Canaccord Genuity Growth Conference | - | RNS | ||
| 30.07.25 | Diaceutics PLC - PDMR Shareholding/Share Incentive Plan and TVR | - | RNS | ||
| 29.07.25 | Diaceutics beruft Lauren DeWitt zur neuen Chefjuristin und Group Company Secretary | 1 | Investing.com Deutsch | ||
| 29.07.25 | Diaceutics appoints Lauren DeWitt as general counsel and secretary | 2 | Investing.com | ||
| 29.07.25 | Diaceutics PLC - Diaceutics Announces Key Leadership Appointment | - | RNS | ||
| 23.07.25 | Diaceutics vergibt Optionen an Führungskräfte und Schlüsselpersonal | 1 | Investing.com Deutsch | ||
| 23.07.25 | Diaceutics issues share options to directors and key staff | 1 | Investing.com | ||
| 23.07.25 | Diaceutics PLC - Issue of Share Options / PDMR Shareholdings | - | RNS | ||
| 22.07.25 | Diaceutics bestätigt Jahresprognose nach starkem Umsatzwachstum im H1 | 2 | Investing.com Deutsch | ||
| 22.07.25 | Diaceutics maintains FY targets with 22% revenue growth in H1 | 2 | Investing.com | ||
| 22.07.25 | Diaceutics PLC - 22% Revenue Growth H125 representing 3-yr CAGR 25% | - | RNS | ||
| 17.07.25 | Diaceutics PLC - Expansion of PMx Commercialization Partnership | 1 | RNS |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| DEXCOM | 60,21 | +0,65 % | Dexcom touts future at CES with new CEO Leach now leading | ||
| ATOSSA THERAPEUTICS | 0,585 | +3,91 % | Atossa Therapeutics Inc: Atossa Therapeutics Receives FDA "Study May Proceed" Letter for (Z)-Endoxifen Investigational New Drug Application for Metastatic Breast Cancer | SEATTLE, Jan. 6, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing innovative medicines for unmet... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| SENSEONICS | 5,600 | +3,70 % | Senseonics Holdings, Inc. - 8-K, Current Report | ||
| VYOME | 3,420 | +7,89 % | Morning Market Movers: SciSparc, Vyome Holdings, Presidio Property Trust, FG Nexus See Big Swings | BEIJING (dpa-AFX) - At 7:55 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| INTELLIGENT BIO SOLUTIONS | 11,840 | +10,97 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Announces New Manufacturing Partnership to Strengthen Global Production Capability and Increase Margins | NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing... ► Artikel lesen | |
| PAVMED | 7,380 | +5,73 % | PAVmed Inc.: PAVmed Announces Reverse Stock Split | NEW YORK, Dec. 30, 2025 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 46,310 | +0,46 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,180 | -2,59 % | EILMELDUNG: Fresenius Medical Care-Aktie im freien Fall - Anleger fliehen aus dem Wert! | ||
| FRESENIUS | 48,970 | +1,09 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,510 | -2,85 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| PROGYNY | 26,800 | +0,49 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,200 | -0,94 % | Citizens reiterates Market Outperform rating on Privia Health stock | ||
| PROCEPT BIOROBOTICS | 33,920 | -2,30 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| GENEDX | 136,55 | +0,55 % | GeneDx to launch whole genome sequencing test for fetal anomalies |
DIACEUTICS PLC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 1,530 Euro und damit +0,66 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu DIACEUTICS PLC finden Sie auf Wallstreet Online.